Skip to main contentAI and Advanced
/
OXYGENTAPH · BSEBSE SENSEX77,369.11-0.22%BSE |
NIFTY 5024,219.05-0.14%NSE |
NIFTY BANK57,525.95-0.41%NSE |
NIFTY IT30,596.9+0.21%NSE |
NIFTY AUTO29,101.3-0.08%NSE |
NIFTY FMCG47,527.8+0.04%NSE |
NIFTY PHARMA26,339.3-0.08%NSE |
NIFTY 50023,511.75-0.08%NSE |
OX
BSE · Equity shares · Pharmaceuticals-3.19 · -5.00%
Oxygenta Pharmaceutical Ltd OXYGENTAPH
NSE:Not available
BSE:INR 60.66
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsAvailable · provider snapshot
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for OXYGENTAPH
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 63.85
Day rangeINR 60.67 — INR 66.8
52-week rangeINR 48 — INR 70
Volume9,032
Market cap224.34
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)37
Net Income (INR Cr)-2.1
EPS-0.57
Research path: Interpret Oxygenta Pharmaceutical Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
OXYGENTAPHOxygenta Pharmaceutical Ltd1d · INR · BSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
BSE reported results · INR crore
| Metric | Jun-26 | Mar-26 | FY25-26 |
|---|---|---|---|
| Revenue | 37 | 49.61 | 112.98 |
| Net Profit | -2.1 | -1.7 | -17.57 |
| EPS | -0.57 | -0.45 | -4.75 |
| Cash EPS | -0.4 | -0.53 | -4.12 |
| OPM % | 1.54 | 0.58 | -13.35 |
| NPM % | -5.69 | -3.43 | -15.55 |
Fundamentals
Valuation and ratios
Margins
Operating Margin 12m1.54
Net Profit Margin 12m-5.69
Valuation
Price to Sale Ratio6.06
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
- Promoter and promoter group
- 56.54%
- Public shareholders
- 43.46%
- Other shareholders
- 0.00%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE corporate filing · 21 Aug 2026, 5:30 am
Shareholder Meeting / Postal Ballot-Outcome of AGMBSE corporate filing · 21 Aug 2026, 5:30 am
Newspaper AdvertisementBSE corporate filing · 31 Jul 2026, 5:30 am
Intimation Of Book Closure And Cut-Off Date For The 33Rd Annual General Meeting Of Oxygenta Pharmaceutical Limited.BSE corporate filing · 30 Jul 2026, 5:30 am
Reg. 34 (1) Annual Report.BSE corporate filing · 30 Jul 2026, 5:30 am
Submission Of Notice Of 33Rd Annual General Meeting For The Finanical Year 2025-26.BSE corporate filing · 30 Jul 2026, 5:30 am
Corporate actions
Events
- board MeetingsGeneral
- board MeetingsGeneral
- board MeetingsResults
- board MeetingsGeneral
- board MeetingsResults
- board MeetingsResults
- board MeetingsGeneral
- board MeetingsResults
ShareKeyX Community
Discussion and sentiment for Oxygenta Pharmaceutical Ltd
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Not available
Company facts
- Industry
- Pharmaceuticals
- Sector
- Healthcare
- Website
- www.oxygentapharma.com
- Address
- Survey No 252/1,, Aroor Village, Sadasivapet Mandal,, Medak, Telangana, 502291
- NSE Code
- OXYGENTAPH
- BSE Code
- 524636
- Listing date
- 7 Oct 1994
- Face value
- 10
- Market lot
- 1
- CIN
- L24110TG1990PLC012038
- Company email
- cs@oxygentapharma.com; md@oxygentapharma.com; info@oxygentapharma.com
Leadership and officers
- Executive Director
- Mr. Chandra Mouliswar Reddy Gangavaram
- Executive Director
- Mr. Balasubba Reddy Mamilla
- Non-Executive - Non Independent Director
- Mrs. Vedavathi Gangavaram
- Non-Executive - Independent Director
- Mr. Sidda Reddy Kanuparthi
- Non-Executive - Independent Director
- Mr. Veera Reddy Arava
- Non-Executive - Independent Director
- Mrs. Sharvari Swapnil Shinde
- Executive Director
- Mr. Amireddy Venkatesu Reddy
- Non-Executive - Independent Director
- Mr. Janardhana Reddy Yeddula
- Chief Financial Officer
- Mr. Prasad Reddy Battinapatla
- Company Secretary & Compliance Officer
- Ms. Kumkum Bajaj
Questions
Stock FAQ
What is the symbol and ISIN of Oxygenta Pharmaceutical Ltd?
Oxygenta Pharmaceutical Ltd has the symbol OXYGENTAPH and ISIN - INE102E01018.
What is the current price of Oxygenta Pharmaceutical Ltd?
Oxygenta Pharmaceutical Ltd is currently trading at INR 60.66.
What are the year high and year low of Oxygenta Pharmaceutical Ltd?
Oxygenta Pharmaceutical Ltd has a year high of INR 70.00 and a year low of INR 48.00.
What is the market capitalization of Oxygenta Pharmaceutical Ltd?
Oxygenta Pharmaceutical Ltd has a market capitalization of INR 224.34 crore.
What is the P/E ratio of Oxygenta Pharmaceutical Ltd?
Oxygenta Pharmaceutical Ltd has a P/E ratio of NA.
What is the dividend yield of Oxygenta Pharmaceutical Ltd?
Oxygenta Pharmaceutical Ltd has a dividend yield of NA.
How is the financial performance of Oxygenta Pharmaceutical Ltd based on revenue, net income, and EPS?
Oxygenta Pharmaceutical Ltd has revenue of INR 37.00 crore, net income of INR -2.10 crore, and EPS of NA.
What is the book value of Oxygenta Pharmaceutical Ltd?
Oxygenta Pharmaceutical Ltd has a book value of NA.
What is the debt-to-equity ratio of Oxygenta Pharmaceutical Ltd?
Oxygenta Pharmaceutical Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Oxygenta Pharmaceutical Ltd?
Oxygenta Pharmaceutical Ltd has a price-to-book ratio of NA and a price-to-sales ratio of 6.06.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.